Reported 8 months ago
On June 18, 2024, the Legislative Yuan passed the regenerative medicine dual law, coupled with the hot topic of contact lenses, leading to foreign investments heavily supporting Synoland and Jasco on the 18th. Synoland stock rose by 5.03% to NT$96.1 with foreign investors buying 365 shares; and Jasco rose by 3.47% to NT$491.5 with foreign investors buying 120 shares due to the upcoming peak season for contact lens shipments in the second half of the year. Synoland has recently garnered market favor with various developments and initiatives including becoming a key player in the regenerative medicine field and planning to list its subsidiary, Synoland Cell Intelligence Medicine, on the emerging stock market by 2025.
Source: YAHOO